Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

NCT00251316 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NIH

Sponsor class

Conditions

Thyroid Cancer
Differentiated Thyroid Carcinoma

Interventions

DRUG: Lithium Carbonate
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)